Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/33027039/ below:

The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities

Affiliations

• ¹ Department of Family & Community Medicine, Joe R & Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, United States.
• ² Center on Smart and Connected Health Technologies, Mays Cancer Center, School of Nursing, UT Health San Antonio, San Antonio, TX, United States.
• ³ Department of Medicine, Joe R & Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, United States.
• ⁴ Department of Pediatrics, Joe R & Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, United States.
• ⁵ School of Nursing, UT Health San Antonio, San Antonio, TX, United States.

• PMID: 33027039
• PMCID: PMC7599065
• DOI: 10.2196/21697

Item in Clipboard

Ramon S Cancino et al. JMIR Cancer. 2020.

• ¹ Department of Family & Community Medicine, Joe R & Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, United States.
• ² Center on Smart and Connected Health Technologies, Mays Cancer Center, School of Nursing, UT Health San Antonio, San Antonio, TX, United States.
• ³ Department of Medicine, Joe R & Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, United States.
• ⁴ Department of Pediatrics, Joe R & Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, United States.
• ⁵ School of Nursing, UT Health San Antonio, San Antonio, TX, United States.

• PMID: 33027039
• PMCID: PMC7599065
• DOI: 10.2196/21697

Item in Clipboard

Cancer is a leading cause of death in the United States and across the globe. Cancer screening is an effective preventive measure that can reduce cancer incidence and mortality. While cancer screening is integral to cancer control and prevention, due to the COVID-19 outbreak many screenings have either been canceled or postponed, leaving a vast number of patients without access to recommended health care services. This disruption to cancer screening services may have a significant impact on patients, health care practitioners, and health systems. In this paper, we aim to offer a comprehensive view of the impact of COVID-19 on cancer screening. We present the challenges COVID-19 has exerted on patients, health care practitioners, and health systems as well as potential opportunities that could help address these challenges.

Keywords: COVID-19; branding; campaign; cancer; cobranding; coronavirus; education; health; screening; social determinants; social media; telemedicine; training.

©Ramon S Cancino, Zhaohui Su, Ruben Mesa, Gail E Tomlinson, Jing Wang. Originally published in JMIR Cancer (http://cancer.jmir.org), 29.10.2020.

PubMed Disclaimer

Conflicts of Interest: RM is a consultant for Novartis, Sierra Oncology, and LaJolla Pharmaceutical and provides research support to Celgene, Incyte, AbbVie Inc, Samus Therapeutics, Genetech, Promedior, and CTI biopharma.

Summary of challenges patients, health…

Summary of challenges patients, health care professionals, and health systems face due to…

Summary of challenges patients, health care professionals, and health systems face due to COVID-19.

• Determinants of Postponed Cancer Screening During the COVID-19 Pandemic: Evidence from the Nationally Representative COVID-19 Snapshot Monitoring in Germany (COSMO).

  Hajek A, De Bock F, Huebl L, Kretzler B, König HH. Hajek A, et al. Risk Manag Healthc Policy. 2021 Jul 14;14:3003-3011. doi: 10.2147/RMHP.S297326. eCollection 2021. Risk Manag Healthc Policy. 2021. PMID: 34285614 Free PMC article.

• Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.

  El-Zein M, Ali R, Farah E, Botting-Provost S, Franco EL; Survey Study Group. El-Zein M, et al. Elife. 2023 Jun 28;12:e83764. doi: 10.7554/eLife.83764. Elife. 2023. PMID: 37377399 Free PMC article.

• Disruption in Cancer Care During Early Survivorship due to the COVID-19 Pandemic and Patient Satisfaction with Telemedicine.

  Bellizzi KM, Ligus K, Fritzson E, Salafia C, Sanft T, Park CL. Bellizzi KM, et al. Support Care Cancer. 2023 Apr 21;31(5):291. doi: 10.1007/s00520-023-07767-7. Support Care Cancer. 2023. PMID: 37084094 Free PMC article.

• The opportunities and challenges of telemedicine during COVID-19 pandemic.

  Gareev I, Gallyametdinov A, Beylerli O, Valitov E, Alyshov A, Pavlov V, Izmailov A, Zhao S. Gareev I, et al. Front Biosci (Elite Ed). 2021 Dec 20;13(2):291-298. doi: 10.52586/E885. Front Biosci (Elite Ed). 2021. PMID: 34937315 Review.

• Impact of COVID-19 on cancer screening: a global perspective.

  Allahqoli L, Mazidimoradi A, Salehiniya H, Alkatout I. Allahqoli L, et al. Curr Opin Support Palliat Care. 2022 Sep 1;16(3):102-109. doi: 10.1097/SPC.0000000000000602. Epub 2022 Jul 18. Curr Opin Support Palliat Care. 2022. PMID: 35862881 Free PMC article. Review.

• Esophagogastroduodenoscopy Screening Intentions During the COVID-19 Pandemic in Japan: Web-Based Survey.

  Akahane T, Nakanishi Y, Yoshiji H, Akahane M. Akahane T, et al. JMIR Cancer. 2022 Nov 11;8(4):e40600. doi: 10.2196/40600. JMIR Cancer. 2022. PMID: 36343187 Free PMC article.

• Bridging the gap in cervical cancer screening for underserved communities: MCED and the promise of future technologies.

  Alshammari AH, Ishii H, Hirotsu T, Hatakeyama H, Morishita M, di Luccio E. Alshammari AH, et al. Front Oncol. 2024 Jul 29;14:1407008. doi: 10.3389/fonc.2024.1407008. eCollection 2024. Front Oncol. 2024. PMID: 39135996 Free PMC article. Review.

• The Influence of SARS-CoV-2 Pandemic in the Diagnosis and Treatment of Cervical Dysplasia.

  Istrate-Ofițeru AM, Berbecaru EI, Ruican D, Nagy RD, Rămescu C, Roșu GC, Iovan L, Dîră LM, Zorilă GL, Țieranu ML, Iliescu DG. Istrate-Ofițeru AM, et al. Medicina (Kaunas). 2021 Oct 14;57(10):1101. doi: 10.3390/medicina57101101. Medicina (Kaunas). 2021. PMID: 34684138 Free PMC article.

• The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials.

  Ali JK, Riches JC. Ali JK, et al. Cancers (Basel). 2021 Nov 25;13(23):5924. doi: 10.3390/cancers13235924. Cancers (Basel). 2021. PMID: 34885038 Free PMC article. Review.

• The 2020 US cancer screening deficit and the timing of adults' most recent screen: a population-based cross-sectional study.

  Semprini J, Ranganathan R. Semprini J, et al. Fam Med Community Health. 2023 Sep;11(3):e001893. doi: 10.1136/fmch-2022-001893. Fam Med Community Health. 2023. PMID: 37730268 Free PMC article.

1. 1. Siegel R, Miller K, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020 Jan;70(1):7–30. doi: 10.3322/caac.21590. - DOI - PubMed
2. 1. COVID-19 forecasts. Centers for Disease Control and Prevention. 2020. [2020-09-01]. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/forecasting-us.html.
3. 1. Waterhouse DM, Harvey RD, Hurley P, Levit LA, Kim ES, Klepin HD, Mileham KF, Nowakowski G, Schenkel C, Davis C, Bruinooge SS, Schilsky RL. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey. JCO Oncology Practice. 2020 Jul;16(7):417–421. doi: 10.1200/op.20.00275. - DOI - PubMed
4. 1. Ren X, Chen B, Hong Y, Liu W, Jiang Q, Yang J, Qian Q, Jiang C. The challenges in colorectal cancer management during COVID-19 epidemic. Ann Transl Med. 2020 Apr;8(7):498–498. doi: 10.21037/atm.2020.03.158. doi: 10.21037/atm.2020.03.158. - DOI - DOI - PMC - PubMed
5. 1. CovidSurg Collaborative Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br J Surg. 2020 Jun 13;107(11):1440–1449. doi: 10.1002/bjs.11746. - DOI - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3